ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.00%
US Dollar vs AUD
1.49209
0.00%
Bitcoin
66,967.09
-0.17%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Shattuck Labs Inc (STTK)

  7. Shattuck Labs Inc (STTK) News

STTK

Shattuck Labs (STTK)

Shattuck Labs Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:STTK
DateTimeSourceHeadlineSymbolCompany
15/05/202406:15GlobeNewswire Inc.Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the EuNASDAQ:STTKShattuck Labs Inc
15/05/202406:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
02/05/202421:05GlobeNewswire Inc.Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:STTKShattuck Labs Inc
10/04/202406:05GlobeNewswire Inc.Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:STTKShattuck Labs Inc
01/04/202422:00GlobeNewswire Inc.Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:STTKShattuck Labs Inc
09/03/202409:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
09/03/202409:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
09/03/202409:29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
07/03/202408:42Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STTKShattuck Labs Inc
04/03/202423:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STTKShattuck Labs Inc
04/03/202423:00GlobeNewswire Inc.Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of DirectorsNASDAQ:STTKShattuck Labs Inc
01/03/202408:41Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:STTKShattuck Labs Inc
01/03/202408:23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:STTKShattuck Labs Inc
01/03/202408:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STTKShattuck Labs Inc
01/03/202408:05GlobeNewswire Inc.Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business HighlightsNASDAQ:STTKShattuck Labs Inc
26/02/202423:00GlobeNewswire Inc.Shattuck Labs Announces Participation in Upcoming March ConferencesNASDAQ:STTKShattuck Labs Inc
14/02/202421:06PR Newswire (US)Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion ProteinsNASDAQ:STTKShattuck Labs Inc
13/02/202422:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STTKShattuck Labs Inc
13/02/202422:00GlobeNewswire Inc.Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory DiseasesNASDAQ:STTKShattuck Labs Inc
03/02/202408:32Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:STTKShattuck Labs Inc
01/02/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:STTKShattuck Labs Inc
01/02/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
01/02/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
01/02/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
25/01/202408:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:STTKShattuck Labs Inc
17/01/202408:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
17/01/202408:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
17/01/202408:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
17/01/202408:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
11/01/202408:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STTKShattuck Labs Inc
 Showing the most relevant articles for your search:NASDAQ:STTK

Your Recent History

BIT
1PAS
WisdomTree Palladium 1x ...
COIN
MELOSUST
MELOS
NASDAQ
GBTS
Gateway Financial
BIT
P1DA49
BNP Paribas Issuance
ASX
DUNO
Dundas Minerals
LQID
BTCEUR
Bitcoin
CSE
TFC
Trichome Financial
USOTC
NIOVF
Plato Gold (QB)
LSE
MBO
Mobilityone
ASE
G220420A2
Republic of Greece
COIN
UBTBTC
UniBright
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved